Cancer survivors spend more out of pocket (OOP) for medical care than their counterparts
without a cancer history, a pattern that persists many years after cancer diagnosis and …

Rising costs of cancer care have led to increased concerns about medical financial hardship
for cancer survivors and their families in the United States. In this commentary, we provide …

Background: A cancer diagnosis can impose substantial medical financial burden on
individuals and may limit their ability to work. However, less is known about worry for …

Abstract “Financial toxicity” has now become a familiar term used in the discussion of cancer
drugs, and it is gaining traction in the literature given the high price of newer classes of …

Purpose To estimate the prevalence of financial hardship associated with cancer in the
United States and identify characteristics of cancer survivors associated with financial …

Background: With rising cancer care costs, including high-priced cancer drugs, financial
hardship is increasingly documented among cancer survivors in the United States; research …

Background: With rising costs of cancer care, this study aims to estimate the prevalence of,
and factors associated with, medical financial hardship intensity and financial sacrifices due …

Advances in cancer diagnosis and treatment have led to increased societal costs and out-of-
pocket patient cost. We reviewed the literature on the impact of out-of-pocket cancer care …

Evidence suggests that a considerably large proportion of cancer patients are affected by
treatment-related financial harm. As medical debt grows for some with cancer, the …

Background: Patients with cancer experience financial toxicity from the costs of treatment, as
well as material and psychologic stress related to this burden. A synthesized understanding …